Nitish Sharma, MD
Interventional Cardiology · Dover, NHNPI 1285188003
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Philips North America LLC at 55.8% of the total. Reporting peaked in 2024 at $15,106 and has fallen 99.0% since, to $149 in 2025. Among interventional cardiology clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 347 payments — averaging $66.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$13K
- Edwards Lifesciences$1K
- AstraZeneca$1K
- Amgen$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$936
- Johnson & Johnson$726
- plus $5K from 33 others
What the payments were for
- Grants$1411%
- Travel & lodging$13,29358%
- Food & beverage$8,82938%
- Education$8324%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 14 | $12,885 |
| Edwards Lifesciences | 11 | $1,269 |
| AstraZeneca(2 entities) | 49 | $1,243 |
| Amgen | 46 | $1,171 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 33 | $936 |
| Johnson & Johnson | 22 | $726 |
| E.r. Squibb & Sons, L.L.C. | 30 | $598 |
| Boehringer Ingelheim | 22 | $568 |
| Abiomed | 14 | $508 |
| Novartis | 23 | $479 |
| Medtronic(2 entities) | 10 | $429 |
| Pfizer | 18 | $419 |
| Abbott | 3 | $347 |
| Cook Incorporated | 1 | $141 |
| Penumbra, Inc. | 2 | $139 |
| Bayer | 5 | $114 |
| Cordis US CORP. | 1 | $102 |
| Amarin Pharma, Inc. | 5 | $100 |
| Boston Scientific | 4 | $99 |
| Cathworks, Inc. | 1 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Chiesi USA, Inc. | 1 | $72 |
| Lexicon Pharmaceuticals, Inc. | 3 | $58 |
| Merck | 3 | $57 |
| AbbVie | 2 | $46 |
| Scpharmaceuticals Inc. | 2 | $46 |
| Cvrx, Inc. | 2 | $44 |
| Gilead | 2 | $44 |
| Shire North American Group Inc | 2 | $39 |
| Novo Nordisk | 2 | $38 |
| Viiv Healthcare Company | 1 | $35 |
| Cardiva Medical, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Biotronik Inc. | 1 | $22 |
| GSK | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| GE HealthCare | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$12,459
- Edwards SAPIEN 3 Transcatheter Heart Valve$335
- ENSITE$238
- ONYX FRONTIER$238
- Repatha$125
- XARELTO$124
- JARDIANCE$104
- MYNX CONTROL$102
How this compares
$23,095 in reported general payments places this provider in the 95th percentile of 26 interventional cardiology providers in New Hampshire.
See all interventional cardiology providers in New Hampshire →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 24 | $133 |
| Losartan Potassium | 16 | $74 |
| Amlodipine Besylate | 18 | $33 |
| Furosemide | 15 | $21 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Dover
- Rodrigo Mendirichaga MaganaDover$21K
- Faisal ShamshadDover$2K
- Shahab MoossaviConcord$36K
- Hannah ChaudryLebanon$20K
- Eric RothsteinLebanon$20K
- James DevriesLebanon$19K
- Xiaoyu Yang-GiulianoManchester$18K
- Lazaro DiazExeter$15K
- Aaron KaplanLebanon$13K
- Augustin DelagoConcord$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.